Pharmacotherapy: A Pathophysiologic Approach, Eighth Edition
8th Edition
Published on 16. April 2011
Book
Hardback
2704 pages
978-0-07-170354-3 (ISBN)
Description
The most comprehensive, widely used, and evidence-based pharmacotherapy text available
Full-color design!
A Doody's Core Title ESSENTIAL PURCHASE for 2011!
5 STAR DOODYS'S REVIEW!
"This is a gold standard reference in pharmacy and the information it provides equips readers with the knowledge base and confidence to provide the highest quality of patient care."--Doody's Review Service
Hailed by Doody's Review Service as "one of the best in pharmacy" Pharmacotherapy: A Pathophysiologic Approach is unmatched in its ability to help students develop a mastery of evidence-based medicine for optimum patient outcomes. The eighth edition will feature the addition of SI units throughout and an increased number of global examples and clinical questions.
Features
Unparalleled guidance in the development of pharmaceutical care plansFull-color presentationKey Concepts in each chapterCritical Presentation boxes summarize common disease signs and symptomsClinical Controversies boxes examin complicated issues you face when providing drug therapyNEW material added to the online learning center EXPANDED evidence-based recommendations EXPANDED coverage of timely issues such as palliative care and pain medicine Therapeutic recommendations in each disease-specific chapter
Full-color design!
A Doody's Core Title ESSENTIAL PURCHASE for 2011!
5 STAR DOODYS'S REVIEW!
"This is a gold standard reference in pharmacy and the information it provides equips readers with the knowledge base and confidence to provide the highest quality of patient care."--Doody's Review Service
Hailed by Doody's Review Service as "one of the best in pharmacy" Pharmacotherapy: A Pathophysiologic Approach is unmatched in its ability to help students develop a mastery of evidence-based medicine for optimum patient outcomes. The eighth edition will feature the addition of SI units throughout and an increased number of global examples and clinical questions.
Features
Unparalleled guidance in the development of pharmaceutical care plansFull-color presentationKey Concepts in each chapterCritical Presentation boxes summarize common disease signs and symptomsClinical Controversies boxes examin complicated issues you face when providing drug therapyNEW material added to the online learning center EXPANDED evidence-based recommendations EXPANDED coverage of timely issues such as palliative care and pain medicine Therapeutic recommendations in each disease-specific chapter
More details
Edition
8th edition
Language
English
Place of publication
New York
United States
Publishing group
McGraw-Hill Education - Europe
Target group
Professional and scholarly
Dimensions
Height: 285 mm
Width: 224 mm
Thickness: 77 mm
Weight
4350 gr
ISBN-13
978-0-07-170354-3 (9780071703543)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide
McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide
McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide
McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide
McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide
L. Michael Posey, RPh, is president of Pharmacy Editorial & News Services (PENS) in Athens, Georgia, and an editor for the APhA periodicals Journal of the American Pharmacists Association, Pharmacy Today, and APhA DrugInfoLine. He also assists with drug information content for APhAs cutting-edge Web site, www.pharmacist.com. During a career spanning two decades as a pharmacy communicator, Posey has served as editor of The Consultant Pharmacist and the American Journal of Hospital Pharmacy, and is an editor of the textbook Pharmacotherapy: A Pathophysiologic Approach.
McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide
McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide
McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide
McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide
L. Michael Posey, RPh, is president of Pharmacy Editorial & News Services (PENS) in Athens, Georgia, and an editor for the APhA periodicals Journal of the American Pharmacists Association, Pharmacy Today, and APhA DrugInfoLine. He also assists with drug information content for APhAs cutting-edge Web site, www.pharmacist.com. During a career spanning two decades as a pharmacy communicator, Posey has served as editor of The Consultant Pharmacist and the American Journal of Hospital Pharmacy, and is an editor of the textbook Pharmacotherapy: A Pathophysiologic Approach.
Content
Section 1: Foundation IssuesSection Editor: L. Michael Posey
1.Pharmacoeconomics: Principles, Methods, and Applications
2.Health Outcomes and Quality of Life
3.Health Literacy and Medication Use
4.Cultural Competency
5.Principles and Practices of Medication Safety
6.Evidence Based Medicine
7.Documentation of Pharmacy Services
8.Clinical Pharmacokinetics and Pharmacodynamics
9.Pharmacogenetics
10.Pediatrics
11.Geriatrics
12.Palliative Care
13. Pharmacoepidemiology
14. Clinical Toxicology
15. Emergency Preparedness: Identification and Management of Biologic Exposures
16. Emergency Preparedness: Identification adn Management of Chemical and Radiologic Exposures
Section 2: Cardiovascular DisordersSection Editor: Robert L. Talbert
17.Cardiovascular Testing
18.Cardiac Arrest
19.Hypertension
20.Systolic Heart Failure
21.Diastolic Heart Failure and the Cardiomyopathies
22.Acute Decompensated Heart
23.Ischemic Heart DiseaseJ
24.Acute Coronary Syndromes
25.The Arrhythmias
26. Venous Thromboembolism
27.Stroke
28.Dyslipidemia
29.Peripheral Arterial Disease
30.Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock
31.Hypovolemic Shock
Section 3: Respiratory DisordersSection Editor: Robert L. Talbert
32.Introduction to Pulmonary Function Testing
33.Asthma
34.Chronic Obstructive Pulmonary Disease
35.Pulmonary Hypertension
36.Drug-Induced Pulmonary Diseases
37.Cystic Fibrosis
Section 4: Gastrointestinal DisordersSection Editor: Joseph T. DiPiro
38.Evaluation of the Gastrointestinal Tract
39.Gastroesophageal Reflux Disease
40.Peptic Ulcer Disease
41.Inflammatory Bowel Disease
42.Nausea and Vomiting
43.Diarrhea, Constipation, and Irritable Bowel Syndrome
44.Portal Hypertension and Cirrhosis
45.Drug-Induced Liver Disease
46.Pancreatitis
47.Viral Hepatitis
48.Drug Therapy Individualization in Patients with Hepatic Disease or Genetic Alterations in Drug Metabolizing Activity
49. Celiac Disease
Section 5: Renal DisordersSection Editor: Gary R. Matzke
50.Clinical Assessment of Kidney Function
51.Acute Kidney Injury
52.Chronic Kidney Disease: Progression-Modifying Therapies
53.Chronic Kidney Disease: Management of Complications
54.Hemodialysis and Peritoneal Dialysis
55.Drug-Induced Kidney Disease
56.Glomerulonephritis
57.Drug Therapy Individualization for Patients with Renal Insufficiency
58.Disorders of Sodium and Water Homeostasis
59.Disorders of Calcium and Phosphorus Homeostasis
60.Disorders of Potassium and Magnesium HomeostasisDonald F. Brophy and Todd W. B. Gehr
61.Acid-Base Disorders
Section 6: Neurologic DisordersSection Editor: Barbara G. Wells
62.Evaluation of Neurologic Illness
63.Alheimer's Disease
64. Multiple Sclerosis
65. Epilepsy
66.Status Epilepticus
67.Acute Management of the Brain Injury Patient
68.Parkinson's Disease
69. Pain Management
70.Headache Disorders
Section 7: Psychiatric DisordersSection Editor: Barbara G. Wells
71.Evaluation of Psychiatric Illness
72.Childhood Disorders
73.Eating Disorders
74.Substance Related Disroders: Overview and Depressahts, Stimulants and Hallucinogens
75.Substance-Related Disorders: Alcohol, Nicotine, and Caffeine
76.Schizophrenia
77.Major Depressive Disorders
78.Bipolar Disorder
79.Anxiety Disorders I: Generalized Anxiety, Panic, and Social Anxiety Disorders
80.Anxiety Disorders II: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder
81.Sleep Disorders
82.Disorders Associated with Intellectual Disabilities83.Diabetes Mellitus
84.Thyroid Disorders
85.Adrenal Gland Disorders
86.Pituitary Gland Disorders
Section 9: Gynecologic and Obstetric DisordersSection Editor: Barbara G. Wells
87.Pregnancy and Lactation: Therapeutic Considerations
88.Contraception
89.Menstruation-Related Disorders
90.Endometriosis
91. Hormone Terapy in Women
Section 10: Urologic DisordersSection Editor: L. Michael Posey
92.Erectile Dysfunction
93.Benign Prostatic Hyperplasia
94.Urinary Incontinence
Section 11: Immunologic DisordersSection Editor: Gary C. Yee
95. Function and Evaluation of the Immune System
96.Systemic Lupus Erythematosus and Other Collagen-Vascular Diseases
97.Allergic and Pseudoallergic Drug Reactions
98.Solid-Organ Transplantation
Section 12: Rheumatologic DisordersSection Editor: L. Michael Posey
99Osteoporosis and Other Metabolic Bone Diseases
100.Rheumatoid Arthritis
101.Osteoarthritis
102. Gout and Hyperuricemia
Section 13: Ophthalmic and Otolaryngological DisordersSection Editor: L. Michael Posey
103.Glaucoma
104.Allergic Rhinitis
Section 14: Dermatologic DisordersSection Editor: L. Michael Posey
105Dermatologic Drug Reactions and Common Skin Conditions
106.Acne Vulgaris
107.Psoriasis
108.Atopic Dermatitis
Section 15: Hematologic DisordersSection Editor: Gary C. Yee
109.Anemias
110.Coagulation Disorders
111. Sickle Cell Disease
112.Drug-Induced Hematologic Disorders
Section 16: Infectious DiseasesSection Editor: Joseph T. DiPiro
113.Laboratory Tests to Direct Antimicrobial Pharmacotherapy
114.Antimicrobial Regimen Selection
115.Central Nervous System Infections
116.Lower Respiratory Tract Infections
117.Upper Respiratory Tract Infections
118.Influenza
119.Skin and Soft Tissue Infections
120.Infective Endocarditis
121.Tuberculosis
122.Gastrointestinal Infections and Enterotoxigenic Poisonings
123.Intraabdominal Infections
124.Parasitic Diseases
125.Urinary Tract Infections and Prostatitis
126.Sexually Transmitted Diseases
127.Bone and Joint Infections
128.Sepsis and Septic Shock
129.Superficial Fungal Infections
130.Invasive Fungal Infections
131.Infections in Immunocompromised Patients
132.Antimicrobial Prophylaxis in Surgery
133.Vaccines, Toxoids, and Other Immunobiologics
134.Human Immunodeficiency Virus Infection
Section 17: Oncologic DisordersSection Editor: Gary C. Yee
135.Cancer Treatment and Chemotherapy
136.Breast Cancer
137.Lung Cancer
138.Colorectal Cancer
139.Prostate Cancer
140.Lymphomas
141.Ovarian Cancer
142.Acute Leukemias
143.Chronic Leukemias
144.Multiple Myeloma
145.Myelodysplastic Syndromes (Web-only)
146.Skin Cancer
147. Melanoma
148. Hematopoietic Stem Cell Transplantation
Section 18: Nutritional DisordersSection Editor: Gary R. Matzke
149.Assessment of Nutrition Status and Nutrition Requirements
150.Medication Administration Considerations With Specialized Nutrition Support
151.Parenteral Nutrition
152.Enteral Nutrition
153.Nutritional Considerations in Major Organ Failure
154.Obesity
Glossary
Index
1.Pharmacoeconomics: Principles, Methods, and Applications
2.Health Outcomes and Quality of Life
3.Health Literacy and Medication Use
4.Cultural Competency
5.Principles and Practices of Medication Safety
6.Evidence Based Medicine
7.Documentation of Pharmacy Services
8.Clinical Pharmacokinetics and Pharmacodynamics
9.Pharmacogenetics
10.Pediatrics
11.Geriatrics
12.Palliative Care
13. Pharmacoepidemiology
14. Clinical Toxicology
15. Emergency Preparedness: Identification and Management of Biologic Exposures
16. Emergency Preparedness: Identification adn Management of Chemical and Radiologic Exposures
Section 2: Cardiovascular DisordersSection Editor: Robert L. Talbert
17.Cardiovascular Testing
18.Cardiac Arrest
19.Hypertension
20.Systolic Heart Failure
21.Diastolic Heart Failure and the Cardiomyopathies
22.Acute Decompensated Heart
23.Ischemic Heart DiseaseJ
24.Acute Coronary Syndromes
25.The Arrhythmias
26. Venous Thromboembolism
27.Stroke
28.Dyslipidemia
29.Peripheral Arterial Disease
30.Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock
31.Hypovolemic Shock
Section 3: Respiratory DisordersSection Editor: Robert L. Talbert
32.Introduction to Pulmonary Function Testing
33.Asthma
34.Chronic Obstructive Pulmonary Disease
35.Pulmonary Hypertension
36.Drug-Induced Pulmonary Diseases
37.Cystic Fibrosis
Section 4: Gastrointestinal DisordersSection Editor: Joseph T. DiPiro
38.Evaluation of the Gastrointestinal Tract
39.Gastroesophageal Reflux Disease
40.Peptic Ulcer Disease
41.Inflammatory Bowel Disease
42.Nausea and Vomiting
43.Diarrhea, Constipation, and Irritable Bowel Syndrome
44.Portal Hypertension and Cirrhosis
45.Drug-Induced Liver Disease
46.Pancreatitis
47.Viral Hepatitis
48.Drug Therapy Individualization in Patients with Hepatic Disease or Genetic Alterations in Drug Metabolizing Activity
49. Celiac Disease
Section 5: Renal DisordersSection Editor: Gary R. Matzke
50.Clinical Assessment of Kidney Function
51.Acute Kidney Injury
52.Chronic Kidney Disease: Progression-Modifying Therapies
53.Chronic Kidney Disease: Management of Complications
54.Hemodialysis and Peritoneal Dialysis
55.Drug-Induced Kidney Disease
56.Glomerulonephritis
57.Drug Therapy Individualization for Patients with Renal Insufficiency
58.Disorders of Sodium and Water Homeostasis
59.Disorders of Calcium and Phosphorus Homeostasis
60.Disorders of Potassium and Magnesium HomeostasisDonald F. Brophy and Todd W. B. Gehr
61.Acid-Base Disorders
Section 6: Neurologic DisordersSection Editor: Barbara G. Wells
62.Evaluation of Neurologic Illness
63.Alheimer's Disease
64. Multiple Sclerosis
65. Epilepsy
66.Status Epilepticus
67.Acute Management of the Brain Injury Patient
68.Parkinson's Disease
69. Pain Management
70.Headache Disorders
Section 7: Psychiatric DisordersSection Editor: Barbara G. Wells
71.Evaluation of Psychiatric Illness
72.Childhood Disorders
73.Eating Disorders
74.Substance Related Disroders: Overview and Depressahts, Stimulants and Hallucinogens
75.Substance-Related Disorders: Alcohol, Nicotine, and Caffeine
76.Schizophrenia
77.Major Depressive Disorders
78.Bipolar Disorder
79.Anxiety Disorders I: Generalized Anxiety, Panic, and Social Anxiety Disorders
80.Anxiety Disorders II: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder
81.Sleep Disorders
82.Disorders Associated with Intellectual Disabilities83.Diabetes Mellitus
84.Thyroid Disorders
85.Adrenal Gland Disorders
86.Pituitary Gland Disorders
Section 9: Gynecologic and Obstetric DisordersSection Editor: Barbara G. Wells
87.Pregnancy and Lactation: Therapeutic Considerations
88.Contraception
89.Menstruation-Related Disorders
90.Endometriosis
91. Hormone Terapy in Women
Section 10: Urologic DisordersSection Editor: L. Michael Posey
92.Erectile Dysfunction
93.Benign Prostatic Hyperplasia
94.Urinary Incontinence
Section 11: Immunologic DisordersSection Editor: Gary C. Yee
95. Function and Evaluation of the Immune System
96.Systemic Lupus Erythematosus and Other Collagen-Vascular Diseases
97.Allergic and Pseudoallergic Drug Reactions
98.Solid-Organ Transplantation
Section 12: Rheumatologic DisordersSection Editor: L. Michael Posey
99Osteoporosis and Other Metabolic Bone Diseases
100.Rheumatoid Arthritis
101.Osteoarthritis
102. Gout and Hyperuricemia
Section 13: Ophthalmic and Otolaryngological DisordersSection Editor: L. Michael Posey
103.Glaucoma
104.Allergic Rhinitis
Section 14: Dermatologic DisordersSection Editor: L. Michael Posey
105Dermatologic Drug Reactions and Common Skin Conditions
106.Acne Vulgaris
107.Psoriasis
108.Atopic Dermatitis
Section 15: Hematologic DisordersSection Editor: Gary C. Yee
109.Anemias
110.Coagulation Disorders
111. Sickle Cell Disease
112.Drug-Induced Hematologic Disorders
Section 16: Infectious DiseasesSection Editor: Joseph T. DiPiro
113.Laboratory Tests to Direct Antimicrobial Pharmacotherapy
114.Antimicrobial Regimen Selection
115.Central Nervous System Infections
116.Lower Respiratory Tract Infections
117.Upper Respiratory Tract Infections
118.Influenza
119.Skin and Soft Tissue Infections
120.Infective Endocarditis
121.Tuberculosis
122.Gastrointestinal Infections and Enterotoxigenic Poisonings
123.Intraabdominal Infections
124.Parasitic Diseases
125.Urinary Tract Infections and Prostatitis
126.Sexually Transmitted Diseases
127.Bone and Joint Infections
128.Sepsis and Septic Shock
129.Superficial Fungal Infections
130.Invasive Fungal Infections
131.Infections in Immunocompromised Patients
132.Antimicrobial Prophylaxis in Surgery
133.Vaccines, Toxoids, and Other Immunobiologics
134.Human Immunodeficiency Virus Infection
Section 17: Oncologic DisordersSection Editor: Gary C. Yee
135.Cancer Treatment and Chemotherapy
136.Breast Cancer
137.Lung Cancer
138.Colorectal Cancer
139.Prostate Cancer
140.Lymphomas
141.Ovarian Cancer
142.Acute Leukemias
143.Chronic Leukemias
144.Multiple Myeloma
145.Myelodysplastic Syndromes (Web-only)
146.Skin Cancer
147. Melanoma
148. Hematopoietic Stem Cell Transplantation
Section 18: Nutritional DisordersSection Editor: Gary R. Matzke
149.Assessment of Nutrition Status and Nutrition Requirements
150.Medication Administration Considerations With Specialized Nutrition Support
151.Parenteral Nutrition
152.Enteral Nutrition
153.Nutritional Considerations in Major Organ Failure
154.Obesity
Glossary
Index